Main Menu

Videos: ICR researchers highlight industry interactions

This series of videos showcases how scientists from The Institute of Cancer Research, London, are collaborating with commercial partners – and promotes new opportunities for industry partners to get involved in their work.

The videos highlight examples of entrepreneurial culture across different research divisions, with several team leaders discussing their experiences of and future plans for industry collaborations.

We have also been featuring these videos in the Business and Innovation Office's quarterly newsletter, Connections.

Watch our featured videos:

  • Developing therapeutic ultrasound

    Professor Gail ter Haar's team are working with industrial partners to help advance their research and get new techniques to patients faster.

  • Better experimental models to help drugs succeed in clinical trials

    Dr Swain leads the ICR's Tumour Profiling Unit, which is designed to accelerate progress towards precision medicine.

  • Access to state-of-the-art sequencing for industry partners

    Staff at the Tumour Profiling Unit support researchers to accelerate progress towards precision therapies.

  • Work with the world’s leading academic centre for drug discovery in oncology

    Professor Collins’ work hugely benefits from collaborating with others.

  • First-in-human phase I trials in collaboration with industry

    Professor Banerji plays a key role bridging pre-clinical and clinical drug development, designing and conducting first-in-human phase I trials of new cancer drugs.

  • Drug development and clinical trials

    Professor Harrington has a track record of successful industry partnerships.

  • Industry partnerships in breast cancer research

    Dr Rachael Natrajan is looking to form partnerships with industry.⠀⠀⠀⠀⠀

  • Technology development at the cutting edge of fundamental biology

    Professor Pines leads the fundamental biology research at the top-ranked higher education institute for Biological Sciences in the UK.


Watch more enterprise videos

Working with pharmaceutical companies

Dr Marco Gerlinger's Translational Oncogenomics Team are keen to develop new partnerships to continue their work, and to access drugs that could reverse the resistance mechanisms that the team has identified so far.


New partnerships in cancer epigenetics

Our Epigenetics and Genome Stability team, led by Professor Jessica Downs, is working on a variety of research programmes that could be developed in collaboration with commercial partners.


Sharing experience with industry partners

Our Molecular and Systems Oncology Team, led by Dr Paul Huang, is keen to collaborate with industry partners on a number of projects on biochemistry, computational modelling, molecular pathology and proteomics.


Collaborating with commercial partners

Our Systems and Precision Cancer Medicine team, led by Dr Anguraj Sadanandam, is investigating ways to stratify tumours based on their genetic and clinical diversity.


Exploring new opportunities for collaborative working

Professor Uwe Oelfke, Deputy Head of the Division of Radiotherapy and Imaging, is keen to explore new opportunities for collaborative working with industry.


The benefits of partnering with industry

Our Molecular Addictions team, led by Dr Igor Vivanco, is working on a variety of projects that could be developed in collaboration with commercial partners.